– USA, CA – CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the appointment of Bryan Riggsbee to its Board of Directors, effective March 11, 2024.
“We’re pleased to welcome Bryan to our Board. His financial expertise, operating background and deep understanding of revenue cycle management in molecular diagnostics will allow him to make meaningful contributions to our Board,” said Board Chair, Michael Goldberg.
Bryan Riggsbee is also joining the Audit and Finance Committee as Chair.
About Bryan Riggsbee
Bryan Riggsbee previously served as CFO at Myriad Genetics, where he made substantial contributions to the company’s growth strategy and business transformation. With a decade-long tenure at Laboratory Corporation of America, he has demonstrated proven financial acumen. His background also includes notable finance roles at General Electric Company. He began his career in the audit division of KPMG and is a Certified Public Accountant licensed in the state of North Carolina.
“I am thrilled to join the CareDx Board, an innovator and leader in the field of organ transplantation,” said Riggsbee. “I look forward to working with the company’s leadership team to advance its mission of improving long-term outcomes by delivering innovative solutions across the entire transplant patient journey.”
About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.
SOURCE: www.CareDx.com.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.